Hello, I am Hyunmin Lee, CEO of STgen Bio.

At its core, the CMO business is defined by manufacturing competitiveness built upon world-class quality capabilities, enabling the consistent delivery of outcomes that meet client expectations. Since our founding, STgen Bio has continuously enhanced its technological expertise and operational efficiency, strengthening its competitive foundation. Especially in 2024, we successfully passed inspections by both the U.S. FDA and the European EMA, officially confirming that our quality standards and manufacturing systems fully meet global regulatory requirements.

We do not stop here.
We continue to strengthen our quality management systems and build robust frameworks to ensure data integrity, fully honoring our responsibilities and mission as a biopharmaceutical company. For a company handling products that directly impact patients' lives and health, this is not just a basic requirement—it is our highest priority and a promise that we are committed to keeping.

Furthermore, STgen Bio will continue to explore new business models to stay ahead in a changing global environment. By expanding our production infrastructure, investing in next-generation technologies, and strengthening our capabilities to meet global regulatory standards, we will establish a solid foundation to drive future growth.

At STgen Bio, sustainable management is driven by our ongoing pursuit of technological excellence, our dedication to delivering continuously improving customer experiences, and the trust our clients place in us. These values form the backbone of our long-term strength and sustainability.

Through STgen Bio's distinct approach to sustainability, we are committed to ensuring the true success of our customers.

Thank you.